Visualitza HVH - Articles científics per autor "Tabernero, Josep"
Ara mostrant els elements 21-30 d 30
-
Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma
Rüschoff, Josef; Lolkema, Martijn; GIANNI, LUCA; Voest, Emile; de Vries, Elisabeth; Tabernero, Josep (Wiley, 2023-06) -
Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments
Matito, Judit; Comas Navarro, Raquel; García, Ariadna I.; MARTINI, Giulia; Martin, Anne Marie; Ros, Javier; Villacampa Javierre, Guillermo; Baraibar, Iosune; Saoudi Gonzalez, Nadia; Salvà, Francesc; Toledo, Rodrigo; Tabernero, Josep; Vivancos, Ana; Elez, Elena; Dienstmann, Rodrigo (Elsevier, 2023-06) -
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
Brahmer, Julie Renee; Hamid, Omid; Garon, Edward; Herbst, Roy; Long, Georgina; André, Thierry; Tabernero, Josep (Elsevier, 2024-03) -
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAFV600E-mutant mCRC
Kopetz, Scott; Bekaii-Saab, Tanios; Elez, Elena; Tabernero, Josep; taieb, julien; Yoshino, Takayuki (Future Science Group, 2024-04) -
Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver
Ros, Javier; vaghi, caterina; Garcia Rodriguez, Ariadna; Alcaraz Soler, Adriana; Baraibar, Iosune; Saoudi Gonzalez, Nadia; R Castells, Marta; Salvà, Francesc; Tabernero, Josep; Elez, Elena (MDPI, 2024-03-14) -
The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey
Garcia Rodriguez, Ariadna; R Castells, Marta; Baraibar, Iosune; Ros, Javier; Saoudi Gonzalez, Nadia; Salvà, Francesc; Alcaraz Soler, Adriana; Tabernero, Josep; Elez, Elena (Frontiers Media, 2023-10-16) -
Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors
Le Tourneau, Christophe; Becker, Heiko; Claus, Rainer; Ricci, Francesco; Fritsch, R.; Elez, Elena; Tabernero, Josep (Elsevier, 2022-10) -
UNCAN.eu: Toward a European Federated Cancer Research Data Hub
Boutros, Michael; Baumann, Michael; Bigas, Anna; Chaabane, Linda; Guérin, Julien; Habermann, Jens; Tabernero, Josep (American Association for Cancer Research, 2024-01-01) -
Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications
R Castells, Marta; Garcia Rodriguez, Ariadna; Alcaraz Soler, Adriana; Vega Cano, Kreina Sharela; Bueno Salazar, Sergio Andrés; Saoudi Gonzalez, Nadia; Salvà, Francesc; Ros, Javier; Baraibar, Iosune; Tabernero, Josep; Elez, Elena (MDPI, 2023-08-08) -
Use of Drugs in Clinical Practice and the Associated Cost of Cancer Treatment in Adult Patients with Solid Tumors: A 10-Year Retrospective Cohort Study
Carreras Soler, Maria Josep; Tomás-Guillén, Elena; Farriols Danes, Anna Maria; Valdivia Vadell, Carolina; Vidal, Jana; Gorgas, Maria Queralt; Renedo-Miró, Berta; Saura Manich, Cristina; Carles, Joan; FELIP, ENRIQUETA; Tabernero, Josep (MDPI, 2023-08-30)